Clinical trial
STAAR-3 Clinical Study
NCT00369733 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00369733 |
|---|---|
| Title | STAAR-3 Clinical Study |
| Official title | Disease/Case Management of Patients Receiving ARANESP™ (Darbepoetin Alfa) to Treat the Anemia of Chronic Renal Insufficiency (CRI) |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, Chronic Renal Insufficiency, Kidney Disease, Pre-dialysis, Pre-ESRD |
| Intervention type | Drug |
| Interventions | Darbepoetin alfa |
| Enrollment | 443 |
| Start date | May 1, 2002 |
| Primary completion | Mar 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Aug 29, 2006 |
| Last update posted | Feb 19, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: